BlackRock Inc. - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 23 filers reported holding MOLECULIN BIOTECH INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2020$34,000
-5.6%
43,5370.0%0.00%
Q3 2020$36,000
-14.3%
43,5370.0%0.00%
Q2 2020$42,000
-50.6%
43,537
-68.8%
0.00%
Q1 2020$85,000
-33.1%
139,612
+1.1%
0.00%
Q4 2019$127,000
+7.6%
138,150
+29.7%
0.00%
Q3 2019$118,000
-16.3%
106,511
-5.4%
0.00%
Q2 2019$141,000
+261.5%
112,572
+134.8%
0.00%
Q1 2019$39,000
-27.8%
47,940
-6.4%
0.00%
Q4 2018$54,000
-34.9%
51,216
-1.8%
0.00%
Q3 2018$83,000
-6.7%
52,152
+4.2%
0.00%
Q2 2018$89,000
+323.8%
50,046
+180.1%
0.00%
Q1 2017$21,00017,8680.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q3 2018
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 101,781$81,0000.01%
Levy Wealth Management Group, LLC 14,036$11,0000.01%
WOODMONT INVESTMENT COUNSEL LLC 12,000$10,0000.00%
Renaissance Technologies 948,503$756,0000.00%
Qube Research & Technologies Ltd 132,238$105,0000.00%
Core Wealth Advisors, Inc. 1,711$1,0000.00%
UBS Group AG 36,726$29,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 12,342$10,0000.00%
TRUE Private Wealth Advisors 2,500$1,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders